secoisolariciresinol diglucoside [Supplementary Concept] major precursor of mammalian lignans; structure given in first source; RN given refers to B-D-GLUCO isomer
Secoisolariciresinol Diglucoside has been studied across 17 research domains including 🔬 Inflammation, 🔥 Metabolic, 🧘 Stress & Anxiety, 🔬 Oncology, ❤️ Cardiovascular. The primary research focus is 🔬 Inflammation with 36% of studies addressing this area.
This evidence profile for Secoisolariciresinol Diglucoside is generated deterministically from 123 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.